Reckitt Benckiser disappoints but headwinds should ease

Josh White Sharecast | 21 Apr, 2017 08:19 - Updated: 12:01 | | |

Reckitt Benckiser, consumer goods, Cillit Bang, Vanish
  • 7,287.00
  • -0.25%-18.00
  • Max: 7,321.78
  • Min: 7,262.00
  • Volume: 1,318,534
  • MM 200 : n/a
17:25 26/04/17
  • 7,288.72
  • 0.18%13.08
  • Max: 7,302.57
  • Min: 7,262.32
  • Volume: 0
  • MM 200 : n/a
17:18 26/04/17
  • 4,056.18
  • 0.23%9.47
  • Max: 4,062.69
  • Min: 4,039.13
  • Volume: 0
  • MM 200 : n/a
17:18 26/04/17
  • 4,001.88
  • 0.24%9.68
  • Max: 4,008.00
  • Min: 3,985.03
  • Volume: 0
  • MM 200 : n/a
17:18 26/04/17
  • 18,024.63
  • -0.08%-14.58
  • Max: 18,112.86
  • Min: 17,983.65
  • Volume: 0
  • MM 200 : n/a
17:18 26/04/17

Consumer products group Reckitt Benckiser posted a trading update for its first quarter on Friday, reporting it was in line with expectations with continued strong performance in the health division led by Mucinex and Durex.

However, sales in the quarter were slightly behind analyst consensus as negative like-for-like sales in Europe were offset by growth in developing markets and foods.

The FTSE 100 firm said that growth was offset by headwind in Scholl/Amopé, which also impacted Europe-North America performance.

Growth rates were set to improve through the year, and RB said it was on track for its full year net revenue target of 3% like-for-like.

The company said home and portfolio categories, and the DvM emerging market area, were negatively impacted by what the it called the “Korea HS issue”, whereby it was still dealing with the legacy of faulty Oxy RB-branded humidity sterilisers distributed in the 1990s and 2000s that caused a number of deaths.

The Mead Johnson acquisition remained on track for completion by the end of the third quarter, it added, and confirmed the strategic review of the Food business had commenced.

“Our Q1 results are in line with expectations as macro conditions remain challenging,” said CEO Rakesh Kapoor.

“Against this backdrop our underlying business remains strong.”

Kapoor said RB delivered continued outperformance in consumer health and good growth in DvM, offset by previously flagged headwinds, which would persist during the first half.

“I expect our growth trajectory to improve as we progress through the year and we remain on track to achieve our full year net revenue target of 3% LFL growth.”

Charlie Huggins, a fund manager for Hargreaves Lansdown, said it was the first quarter he can remember where the group has failed to grow its like-for-like sales and that most of the headwinds should ease as the year progresses.

"We don’t think for one minute that Reckitt’s brands are losing their fundamental appeal, or that the company has lost its ability to innovate.

"We expect this brand strength, supported by the company’s huge marketing clout, to drive growth in the longer term. The investment case also depends on Reckitt’s ability to integrate the Mead Johnson acquisition, which is expected to complete at the end of the third quarter."

More news

26 Apr US close: Markets fall as investors react to Trump tax plan

US stocks were down on Wednesday as investors digested the details of President Donald Trump’s tax reform.

26 Apr Le Pen's long odds attract new punters to French political betting

Gamblers have been piling in to bet on far-right candidate Marine Le Pen wrestling a surprise win over centrist candidate Emmanuel Macron next month, according to bookmakers.

26 Apr Thursday preview: Dovish ECB expected, WPP could turn cautious

The European Central Bank is forecast to leave its main policies unchanged in its meets this week, following a March meeting when the market made a rather hawkish interpretation of the outcome.

26 Apr Commodities: Crude bounces off lows as EIA data shows fall in US inventories

Crude futures bounced off earlier lows on Wednesday afternoon as US Energy Information Administration (EIA) data showed a surprise fall in inventories last week.

26 Apr Twitter shares jump as traffic continues to accelerate in Q1

Twitter continued to be mired in red ink during the first quarter despite continued and accelerating growth of activity on its site, amid revenue headwinds.

26 Apr US open: Stocks little changed as investors eye Trump tax announcement

US stocks were little changed on Wednesday as investors awaited a speech on tax reform by President Donald Trump.

26 Apr Small cap news round-up

Glanbia is to sell a 60% stake in its Irish dairy business, to Glanbia Co-operative Society for €112m.

26 Apr FTSE 250 movers: Aggreko gains ahead of update, Tullow gushes lower

London's FTSE 250 index was up 0.5% to 19,670.48 in afternoon trade.

26 Apr WTI futures spike higher following DoE inventory data

US crude oil inventories fell sharply last week despite rising imports as product stockpiles continued to build.

26 Apr FTSE 100 movers: Standard Chartered rallies on results, GKN drops

London's FTSE 100 was up 0.2% to 7,287.12 in afternoon trade as investors digested comments from US Treasury Secretary Steven Mnuchin, who confirmed that Donald Trump plans to cut corporate tax to 15% from 35%.